{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:18:44Z","timestamp":1751948324670,"version":"3.41.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Nederlandse Hartstichting","doi-asserted-by":"publisher","award":["03-006-2022-0052"],"award-info":[{"award-number":["03-006-2022-0052"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.rpth.2025.102694","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:34:30Z","timestamp":1738348470000},"page":"102694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9185-8974","authenticated-orcid":false,"given":"Dagmar J.M.","family":"van Mourik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie L.B.I.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo ten","family":"Cate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry R.","family":"B\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri M.H.","family":"Spronk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdolna","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thijs E.","family":"van Mens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.102694_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102694_bib2","doi-asserted-by":"crossref","first-page":"SI24","DOI":"10.1093\/rheumatology\/kead571","article-title":"Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations","volume":"63","author":"Gaspar","year":"2024","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.rpth.2025.102694_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rpth.2025.102694_bib4","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rpth.2025.102694_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780400509","article-title":"Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression","volume":"40","author":"Cuadrado","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rpth.2025.102694_bib6","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/bloodadvances.2021006620","article-title":"Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19","volume":"6","author":"Henderson","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102694_bib7","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.120.050656","article-title":"Neutrophils and contact activation of coagulation as potential drivers of COVID-19","volume":"142","author":"Busch","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.102694_bib8","first-page":"217","article-title":"Autoimmune factors in assisted reproduction","volume":"54","author":"Kutteh","year":"2002","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.rpth.2025.102694_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rth2.12217","article-title":"The contact pathway and sepsis","volume":"3","author":"Raghunathan","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102694_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/ATVBAHA.118.312130","article-title":"Intrinsic pathway of coagulation and thrombosis","volume":"39","author":"Grover","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2025.102694_bib11","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.3389\/fimmu.2019.02734","article-title":"Neutrophils-important communicators in systemic lupus erythematosus and antiphospholipid syndrome","volume":"10","author":"Wirestam","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2025.102694_bib12","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/rheumatology\/key067","article-title":"Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome","volume":"57","author":"van der Linden","year":"2018","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.rpth.2025.102694_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/cbf.3363","article-title":"Anti-beta2GPI\/beta2GPI induces human neutrophils to generate NETs by relying on ROS","volume":"37","author":"You","year":"2019","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.rpth.2025.102694_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in\u00a0vivo","volume":"209","author":"von Bruhl","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rpth.2025.102694_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/M19-0291","article-title":"Rivaroxaban versus vitamin K antagonist in antiphospholipid syndrome: a randomized noninferiority trial","volume":"171","author":"Ordi-Ros","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2025.102694_bib16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.102694_bib17","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/bloodadvances.2021005808","article-title":"Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial","volume":"6","author":"Woller","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.102694_bib18","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.118.035612","article-title":"Non-vitamin K antagonist oral anticoagulants for mechanical heart valves: is the door still open?","volume":"138","author":"Aimo","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.102694_bib19","first-page":"4984","article-title":"DOACs in the anticoagulation of mechanical valves: a systematic review and future perspectives","volume":"12","author":"Langenaeken","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.rpth.2025.102694_bib20","doi-asserted-by":"crossref","first-page":"B65","DOI":"10.1093\/eurheartjsupp\/suad070","article-title":"The new in anticoagulation: factor XI inhibitors","volume":"25","author":"Muscente","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.rpth.2025.102694_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ehjcvp\/pvae002","article-title":"Pharmacological and clinical appraisal of factor XI inhibitor drugs","volume":"10","author":"Occhipinti","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.rpth.2025.102694_bib22","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1538-7836.2007.02687.x","article-title":"The plasma kallikrein-kinin system and risk of cardiovascular disease in men","volume":"5","author":"Govers-Riemslag","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.102694_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2021.11.027","article-title":"Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19","volume":"209","author":"Willems","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.102694_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ejh.12610","article-title":"Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives","volume":"95","author":"Gomez-Outes","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2025.102694_bib25","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2025.102694_bib26","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rpth.2025.102694_bib27","article-title":"Low density granulocytes and neutrophil extracellular trap formation are increased in incomplete systemic lupus erythematosus","author":"Henning","year":"2024","journal-title":"Rheumatol (Oxf Engl)"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:54:15Z","timestamp":1751932455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2475037925000184"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102694","relation":{},"ISSN":["2475-0379"],"issn-type":[{"type":"print","value":"2475-0379"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.102694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102694"}}